Posts

Showing posts with the label Anti-body Coupled T Receptor Therapy Market

Anti-body Coupled T Receptor Therapy Market - Global Industry Insights, Trends, Outlook and Opportunity Analysis

Image
  Anti-body coupled T receptor (ACTR) therapy is sort of immunotherapy used to treat cancer by which body's own immune response is utilized to do something on cancerous cell. Anti-body coupled T receptor therapy utilizes T cells from body, engineered it to express specific T cell receptor, multiplying it in lab and then administering it along side targeting antibodies. The benefit in this process is, why these T cells do not attack normal antigens from blood circulation but attack only antigens attached with the cancerous cells. That is possible as tumor specific monoclonal antibodies are shown along with ACTR T cells. ACTR therapy is cost effective because it can be utilized in several cancer therapy. Also, greater therapeutic benefit with minimum negative effects can be possible by adjusting the amount of targeting antibody that will be essential for activation of the ACTR T cells. ACTR therapy is much better in its approach than other adoptive T cell transfer te...